Analysed INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) News Sources
Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
09-01-2026
yahoo.com
Eli Lilly Broadens Genetic Medicine Portfolio While Shares Screen As Undervalued
11-02-2026
yahoo.com
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer
13-02-2026
yahoo.com
What is the current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is $54.29.
INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is $4.998.
INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is 10.1396%.
What is the most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is 76 out of 100.
What is the most recent average sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?
The most recent sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is .
SEC-8K** Filing Available For INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.